Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A Nationwide Study

(2015) Jyh-Ming Liou et al.   PLoS One

The Problem of Helicobacter pylori Resistance to Antibiotics: A Systematic Review in Latin America

(2014) M Constanza Camargo et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials

(2014) A. C. Ford et al.   BMJ-British Medical Journal

Evidence-based recommendations for successfulHelicobacter pyloritreatment

(2014) Jeng-Yih Wu et al.   Expert Review of Gastroenterology & Hepatology

Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

(2013) David Y. Graham et al.   Clinical Gastroenterology and Hepatology

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

(2013) L. Gatta et al.   BMJ-British Medical Journal

Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection

(2012) Alessandro Federico et al.   GASTROENTEROLOGY

The benefit of mass eradication ofHelicobacter pyloriinfection: a community-based study of gastric cancer prevention

(2012) Yi-Chia Lee et al.   GUT

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Levofloxacin-containing Triple and Sequential Therapy or Standard Sequential Therapy as the First Line Treatment forHelicobacter pyloriEradication in China

(2012) Juan Qian et al.   HELICOBACTER

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial

(2012) J.-M. Liou et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection

(2012) Javier P. Gisbert et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

(2012) Jyh-Ming Liou et al.   LANCET

Levofloxacin Based Sequential and Triple Therapy Compared with Standart Plus Probiotic Combination for Helicobacter Pylori Eradication

(2011) Kamil Özdil et al.   HEPATO-GASTROENTEROLOGY

Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial

(2011) J.-M. Liou et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

(2011) E Robert Greenberg et al.   LANCET

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

(2011) Peter Malfertheiner et al.   LANCET

Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? authors’ reply

(2010) J. Molina-Infante et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Genotypic Resistance inHelicobacter pyloriStrains Correlates with Susceptibility Test and Treatment Outcomes after Levofloxacin- and Clarithromycin-Based Therapies

(2010) Jyh-Ming Liou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Helicobacter pylori Eradication Therapy Research: Ethical Issues and Description of Results

(2010) David Y. Graham   Clinical Gastroenterology and Hepatology

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

(2010) M. Romano et al.   GUT

Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design

(2010) J. M. Liou et al.   GUT